Position in HLN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,931
-$1,532 QoQ
Shares Held
207
-40.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#573
of 640 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HighMark Wealth Management LLC holds $55,297 across 10 Drug Manufacturers - Specialty & Generic names. HLN ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORGO |
Organogenesis Holdings Inc.
|
11,829 | $28,744 | |
| 2 | CRON |
Cronos Group Inc.
|
3,000 | $8,340 | |
| 3 | VTRS |
Viatris Inc
|
509 | $8,082 | |
| 4 | TLRY |
Tilray Brands, Inc.
|
747 | $3,354 | |
| 5 | LQDA |
Liquidia Corp
|
25 | $1,993 | |
| 6 | HLN |
Haleon plc
This page
|
207 | $1,931 | |
| 7 | TRLV |
Trulieve Cannabis Corp.
|
120 | $1,179 | |
| 8 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
55 | $1,109 |
All Filings in HLN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,931 | 207 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,463 | 346 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,012 | 298 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,058 | 341 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $3,525 | 340 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $3,478 | 338 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $3,224 | 338 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $3,576 | 338 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,783 | 337 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,844 | 335 | Shares | Sole | 2024-04-29 | |
| No filing history on record for this holder in this stock. | ||||||